Milestone Pharmaceuticals (MIST)
(Delayed Data from NSDQ)
$1.70 USD
+0.07 (3.98%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.67 -0.03 (-1.76%) 4:56 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -6.67% |
ABR | 1.50 |
Earnings ESP
|
-19.23% |
---|---|
Current Year | -1.15 |
Next Year | -1.55 |
EPS (TTM) | -1.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 18.00M |
# of Estimates | NA | NA | NA | 3 |
High Estimate | NA | NA | NA | 41.20M |
Low Estimate | NA | NA | NA | 1.80M |
Year ago Sales | 1.00M | 0.00M | 1.00M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.23 | -1.15 | -1.55 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.21 | -0.21 | -0.85 | -0.66 |
High Estimate | -0.21 | -0.18 | -0.81 | -0.66 |
Low Estimate | -0.31 | -0.30 | -1.59 | -2.36 |
Year ago EPS | -0.35 | -0.37 | -1.39 | -1.15 |
Year over Year Growth Est. | 25.71% | 37.84% | 17.27% | -34.35% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.23 | -1.15 | -1.55 |
7 Days Ago | -0.26 | -0.23 | -1.15 | -1.55 |
30 Days Ago | -0.24 | -0.23 | -1.21 | -1.61 |
60 Days Ago | -0.35 | -0.36 | -1.62 | -1.79 |
90 Days Ago | -0.37 | -0.40 | -1.71 | -1.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.23 | -1.59 | -1.65 |
Zacks Consensus Estimate | -0.26 | -0.23 | -1.15 | -1.55 |
Earnings ESP | -19.23% | 0.00% | -38.26% | -6.80% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.35 | -0.37 | -0.35 | NA |
Estimate | -0.30 | -0.38 | -0.39 | -0.38 | NA |
Difference | -0.02 | 0.03 | 0.02 | 0.03 | 0.02 |
Surprise | -6.67% | 7.89% | 5.13% | 7.89% | 3.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more